Lestaurtinib has undergone clinical trials for the treatment of various cancers, including pancreatic and prostate cancers, V617F JAK2 positive polycythemia vera and essential thrombocytosis, and refractory neuroblastoma. Reference standards of Lestaurtinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Lestaurtinib-API [catalogue_number] => PA 12 1530000 [category_ids] => ,77,123,81,69,75,76,78,70,82, [chemical_name] => [weight] => 439.47 [form] => C26H21N3O4 [cas] => 111358-88-4 [pslug] => 111358-88-4-lestaurtinib-api-pa121530000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 12 1530000
CAS :
Molecular Formula : C26H21N3O4
Molecular Weight : 439.47
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....